Mayo Clinic again Named among Disability Equality Index Best Places to Work - Insights
Mayo Clinic has again received a top score on the Disability Equality Index, or DEI, and designation as a 2018 Disability Equality Index Best Place to Work.
Mayo Clinic Laboratory and Pathology Research Roundup: May 29 - Insights
This week’s Research Roundup highlights the evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers.
Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D., explain why Mayo Clinic Laboratories' gene panel is the most comprehensive test available for inherited Parkinson's disease. The new panel covers all mutations known to cause the...
Destination Laboratory - Insights
Around 5 o’clock each morning, approximately 500 cranberry colored boxes arrive at Rochester International Airport from the Federal Express hub in Memphis, Tennessee. The boxes, created by Mayo Clinic Laboratories to allow FedEx staff to...
Hereditary movement disorders - Insights
Learn about our advanced genetic testing for hereditary movement disorders, including ataxias, Huntington’s disease, and Parkinson’s disease.
Hereditary movement disorders - Insights
Learn about our advanced genetic testing for hereditary movement disorders, including ataxias, Huntington’s disease, and Parkinson’s disease.
Acquired Neuropathy Diagnostic Algorithm
Acquired Neuropathy Diagnostic Algorithm
A new comprehensive genetic panel redefines Parkinson's disease diagnosis - Insights
Mayo Clinic Laboratories introduces the Inherited Parkinson’s Disease Gene Panel (Mayo ID: PARDP), a collaborative breakthrough poised to transform Parkinson’s disease diagnosis and treatment. Led by Rodolfo Savica, M.D., Ph.D., and Zhiyv...
wes-wgs-information-test-ordering-guide.pdf
GEN ETICS +Turnaround time begins upon receipt of all samples and required paperwork. ^Whole blood is the preferred specimen type. ŧCPT codes 81416 or 81426 are applied to proband when a family member comparator is submitted. This code...
Comprehensive inherited neuropathy panel - Insights
Learn how our comprehensive inherited neuropathy panel simplifies the diagnostic process by evaluating 186 genes with associations to inherited neuropathy.
Mayo Clinic Infectious Disease Study Noted in Clinical Microbiology Newsletter - Insights
An article recently published in the Clinical Microbiology Newsletter made mention of a Mayo Clinic study. The article discussed a topic that has become increasingly popular—self-collected specimens.
Frontotemporal dementia and ALS - Insights
Learn more about how detection of amyotrophic lateral sclerosis and frontotemporal dementia paved the way for gene-targeted therapies for patients.
Mayo Clinic Laboratories releases new, first-to-U.S.-market pregnancy risk assessment - Insights
Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe...
Staffing to Workload in Phlebotomy Areas: On-Site Operational Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on "on-site operational needs," which is defined as "staff effort that does not deal directly with patients or their...
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...
Histiocytic neoplasms - Insights
Learn more about how Mayo Clinic Laboratories’ next-generation sequencing panel for histiocytic neoplasms can help physicians accurately diagnose patients and guide treatment for their patients.
Staffing to Workload in Phlebotomy Areas: Off-Site Operational Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on off-site operational needs, including paid time off and unpaid time off.
The National Kidney Foundation, the American Society for Clinical Pathology, and the nation’s leading laboratories and clinical laboratory societies have announced a new collaboration to remove barriers to testing for chronic kidney...
Cholesterol biosynthesis and transport - Insights
Check out Mayo Clinic Laboratories’ testing approach to diagnose disorders related to cholesterol biosynthesis and transport.
Our serum test is the first preeclampsia-specific test that can be used to stratify patients into low- or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features.
Hereditary Alzheimer's disease and dementia - Insights
Learn about our genetic testing for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and CADASIL.
MCL Neurogenetics Delivering Precision Results Through ExpertBacked Advanced Evaluations MC2775732
MCL Neurogenetics Delivering Precision Results ExpertBacked Advanced Evaluations NEUROGENETICS DELIVERING PRECISION RESULTS EXPERT BACKED ADVANCED EVALUATIONS neurogenetic testing unparalleled scope includes molecular
What's New in Health Care Reform: Jan. 2 - Insights
Top highlights include: "big pharma" returning to raising U.S. prices in January after pause; crowdfunding drives funds and attention toward questionable medical treatments; Americans rate health care providers high on honesty, ethics,...
August 2023 - Clinical Chemistry - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Chemistry.
FDA-approved test expands options for Alzheimer's disease - Insights
Joshua Bornhorst, Ph.D., describes the new, FDA-approved Alzheimer's disease (AD) test and how it differs from Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to ensure flexibility and options for...
Whole exome sequencing - Insights
Learn more about how whole exome sequencing at Mayo Clinic Laboratories can quickly end diagnostic testing odysseys for patients with suspected genetic disorders.
Advancing Multiple Myeloma Diagnosis - Insights
The standard laboratory test to diagnose multiple myeloma dates back to the Eisenhower administration. Research at Mayo Clinic spearheaded by David Murray, M.D., Ph.D. (PATH ’10), and fueled by his experience as an industrial chemist has...
Pathways Case Studies: February 2022 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for February include the following sub-specialties: Clinical Biochemistry, Bone and...
Each day, some 40 to 45 thousand specimens are shipped to Mayo Clinic Laboratories in Rochester, Minnesota, from hospitals and other health care organizations around the world. And for every sample, there’s a patient to whom it belongs,...
In this month’s “Hot Topic,” Robin Patel, M.D., discusses the FilmArray meningitis/encephalitis (ME) panel, describing the panel, her experience with it, and an algorithm for its use.
MCL - Neurology Specialty Testing Client Test Request - MC0767-02A
MCL - Neurology Specialty Testing Client Test Request
Cardiovascular Biomarkers of Atherosclerotic Risk - Insights
In this month’s “Hot Topic,” Vlad Vasile, M.D., Ph.D., reviews ceramides and their atherosclerotic risk through defining ceramides, talking about when they should be tested for and touch on the topic of ceramides in primary prevention.
Top Gun Phlebotomy - Butterfly Use: The Good, the Bad, and the Ugly - Insights
In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., will discuss recent information on the advantages and disadvantages of using butterfly needles for blood collection.
Pathways Case Studies: March 2021 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for March include the following sub-specialties: Pulmonary Pathology, Cardiovascular...
Pleural Mesothelioma - Insights
In this month's "Hot Topic," Anja Roden, M.D., a thoracic pathologist at Mayo Clinic, gives an update on the 2021 World Health Organization (WHO) classification and ancillary testing of pleural mesothelioma.
Pathways Case Studies: July 2022 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for July include the following sub-specialties: Gastroenterology Pathology,...
Pediatric neuro-oncology informative cases - Insights
Neuro-oncology is a complex field undergoing rapid changes with the advancement and evolution of sophisticated genetic testing. Evidence continues to grow in support of broad molecular and cytogenetic analysis for patients with brain...
Pathways Case Studies: April 2022 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for April include the following sub-specialties: Bone and Soft Tissue Pathology,...
Pathways Case Studies: August 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for August include the following sub-specialties: Bone and Soft Tissue Pathology,...
Pathways Case Studies: March 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for March include the following sub-specialties: Breast Pathology, Cytopathology,...